Q1 Results impact: Coffee Day Enterprises, AstraZeneca Pharma shares jump up to 2%, IOC shares in red

Q1 Results impact

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

The shares of Coffee Day Enterprises and AstraZeneca Pharma recorded notable gains on August 18 as markets responded to their respective Q1 results.

The shares of Indian Oil Corporation (IOC) however were trading almost flat with marginal losses.

IOC Q1 Results:

Indian Oil Corporation (IOC) reported a standalone net profit of Rs 5,689 crore for Q1 FY26. This marks a 115 percent YoY rise from the Rs 2,643 crore net profit reported in the year-ago period. The net profit however declined sequentially from the Rs 7,265 crore reported in the previous quarter (Q1 FY25).

The firm's revenue from operations rose 1 percent on-year to Rs 2.19 lakh crore during the April-June quarter of the financial year 2026. EBITDA contribution meanwhile narrowed to Rs 13,220 crore.

The shares of the company were down with marginal losses at Rs 140 apiece, as seen as 12.42 pm. The stock has fallen more than 1 percent in the past five days, and nearly 7 percent in the past one month. The shares of the oil major however gained nearly 18 percent in the past six months.

Coffee Day Enterprises Q1 Results:

Coffee Day Enterprises, the company that operates the popular café chain Café Coffee Day, reported a consolidated net profit of Rs 28 crore for the April-June quarter of the financial year 2026. This marks a sharp improvement from the Rs 11.5 crore net loss reported in the corresponding quarter of the previous financial year.

The firm's revenue from operations meanwhile grew nearly 4 percent on-year to Rs 269 crore, while EBITDA (without one time write-off/gains) dropped 5 percent on-year to Rs 41 crore.

Coffee Day Enterprises shares jumped more than 2 percent to trade at Rs 39 apiece. The shares of the company have jumped more than 8 percent in the past five days, but fell nearly 2 percent in the past one month. The stock however rallied over 82 percent in the past six months.

AstraZeneca Pharma Q1 Results:

AstraZeneca Pharma on August 14 reported a net profit of Rs 56 crore in Q1 FY26, as against a net loss of Rs 12 crore in Q1 FY25. The pharma company's revenue from operations meanwhile rose to Rs 526 crore.

The shares of the pharma player rose more than 1 percent to trade at Rs 8,398 apiece.

Also read: Our LIVE blog on stock market updates

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.